Generated by GPT-5-mini| South East Cancer Network | |
|---|---|
| Name | South East Cancer Network |
| Formation | 20XX |
| Type | Healthcare network |
| Region served | South East England |
| Headquarters | Example City |
| Leader title | Director |
South East Cancer Network The South East Cancer Network is a regional oncology consortium providing coordinated oncology services across the South East of England, linking specialist hospital trusts, tertiary referral centres, and community partners. It coordinates multidisciplinary care pathways between institutions such as Guy's and St Thomas' NHS Foundation Trust, Royal Surrey County Hospital, Brighton and Sussex University Hospitals NHS Trust and regional cancer centres, and works with national bodies including NHS England, National Institute for Health and Care Excellence, and the National Cancer Research Institute to align standards, pathways, and research. The Network aims to integrate surgical, medical, and radiation oncology services across trusts and to improve outcomes for patients with cancers such as breast cancer, colorectal cancer, lung cancer, prostate cancer and haematological malignancies.
The Network functions as a hub-and-spoke system linking specialist centres like Royal Marsden Hospital, Oxford University Hospitals NHS Foundation Trust, and district hospitals across counties including Kent, Surrey, East Sussex and Hampshire. It convenes regional tumour boards with participation from clinicians affiliated with institutions such as University College London Hospitals NHS Foundation Trust, King's College Hospital, University of Southampton Hospitals NHS Foundation Trust, St George's, University of London, and University of Brighton. The Network’s governance interacts with regulators and funders such as Care Quality Commission and Health Education England, and aligns local commissioning with guidance from National Institute for Health and Care Excellence. It supports service delivery encompassing diagnostics (integrating PET-CT centres), surgery (including centres of excellence accredited by Association of Coloproctology of Great Britain and Ireland), systemic therapy, and radiotherapy delivered at centres like Mount Vernon Cancer Centre.
The Network was constituted in response to regional service variation identified in reviews involving stakeholders from NHS England and the Department of Health and Social Care. Early strategic papers referenced models from established centres such as Royal Marsden Hospital and collaborative frameworks used by the Northern and Yorkshire Cancer Network. Governance is organised through a board drawing executives and clinical leads from trusts including Brighton and Sussex University Hospitals NHS Trust, Surrey and Sussex Healthcare NHS Trust, and academic partners such as University of Oxford and King's College London. Subcommittees cover areas managed with input from professional bodies: the Royal College of Physicians, the Royal College of Surgeons of England, the Royal College of Radiologists, and the British Society for Haematology. Workforce development and training dovetail with programmes run by Health Education England and academic fellowships tied to universities like University of Southampton.
Clinical services span multidisciplinary tumour teams for disease sites modelled on pathways from Royal Marsden Hospital and evidence syntheses by the National Institute for Health and Care Excellence. Programs include rapid diagnostic centres working with General Practitioner networks, enhanced recovery after surgery protocols mirroring guidance from the Association of Coloproctology of Great Britain and Ireland, and survivorship initiatives influenced by frameworks from the Macmillan Cancer Support and the Cancer Research UK survivorship portfolio. The Network operates specialised services such as paediatric oncology liaisons aligning with Great Ormond Street Hospital, complex surgical oncology pathways in collaboration with University College London Hospitals, and brachytherapy and stereotactic radiotherapy services coordinated with centres like Royal Surrey County Hospital and Mount Vernon Cancer Centre. Patient navigation and psychosocial support programmes draw on best practices from Marie Curie and local hospice providers including St Wilfrid's Hospice.
The Network supports clinical trials infrastructure linked to the National Cancer Research Institute Clinical Studies Groups and trial units such as the Cancer Research UK Clinical Trials Unit and university-based translational laboratories at University College London and University of Oxford. It facilitates accrual to multicentre studies sponsored by organisations like Cancer Research UK, international cooperative groups such as the European Organisation for Research and Treatment of Cancer, and industry-sponsored protocols from pharmaceutical companies including AstraZeneca and Roche. The Network fosters translational research partnerships with academic centres including King's College London and University of Southampton, enabling biomarker-driven trials in precision oncology and collaborations with genomic services such as Genomics England.
Strategic partnerships extend to academic institutions—King's College London, University of Oxford, University of Southampton, University College London—and professional societies such as the Royal College of Radiologists and the British Association of Surgical Oncology. The Network works with charitable partners including Cancer Research UK, Macmillan Cancer Support, and regional charities to fund patient support and research infrastructure. It liaises with national commissioning bodies such as NHS England and integrates guidance from National Institute for Health and Care Excellence while coordinating with regional ambulance services like South East Coast Ambulance Service for urgent cancer pathways.
Performance metrics are benchmarked against national datasets held by organisations such as NHS England and the National Cancer Registration and Analysis Service; outcomes reporting references survival statistics comparable to peer networks including the North West Cancer Network and West Midlands Cancer Alliance. Quality improvement initiatives have targeted waiting-time standards articulated by NHS England and diagnostic yield improvements reflecting audits by the Royal College of Radiologists. The Network publishes performance dashboards aligned with national indicators and participates in regional audits run with partners such as Cancer Research UK and the National Institute for Health and Care Excellence to reduce variation in access, stage at diagnosis, and treatment outcomes across counties including Kent, Surrey, and East Sussex.
Category:Healthcare in South East England